Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 342

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

COVID-19 and pneumothorax: a multicentre retrospective case series

Open access
Martinelli, Anthony W., Ingle, Tejas, Newman, Joseph, Nadeem, Iftikhar, Jackson, Karl, Lane, Nicholas D., Melhorn, James, Davies, Helen E., Rostron, Anthony J., Adeni, Aldrin, Conroy, Kevin, Woznitza, Nick, Matson, Matthew, Brill, Simon E., Murray, James, Shah, Amar, Naran, Revati, Hare, Samanjit S., Collas, Oliver, Bigham, Sarah, Spiro, Michael, Huang, Margaret M., Iqbal, Beenish, Trenfield, Sarah, Ledot, Stephane, Desai, Sujal, Standing, Lewis, Babar, Judith, Mahroof, Razeen, Smith, Ian, Lee, Kai, Tchrakian, Nairi, Uys, Stephanie, Ricketts, William, Patel, Anant R.C., Aujayeb, Avinash, Kokosi, Maria, Wilkinson, Alexander J.K., Marciniak, Stefan J. · 2020 · European Respiratory Journal

Abstract

Introduction: Pneumothorax and pneumomediastinum have both been noted to complicate cases of coronavirus disease 2019 (COVID-19) requiring hospital admission. We report the largest case series yet described of patients with both these pathologies (including nonventilated patients). Methods: Cases were collected retrospectively from UK hospitals with inclusion criteria limited to a diagnosis of COVID-19 and the presence of either pneumothorax or pneumomediastinum. Patients included in the study presented between March and June 2020. Details obtained from the medical record included demographics, radiology, laboratory investigations, clinical management and survival. Results: 71 patients from 16 centres were included in the study, of whom 60 had pneumothoraces (six with pneumomediastinum in addition) and 11 had pneumomediastinum alone. Two of these patients had two distinct episodes of pneumothorax, occurring bilaterally in sequential fashion, bringing the total number of pneumothoraces included to 62. Clinical scenarios included patients who had presented to hospital with pneumothorax, patients who had developed pneumothorax or pneumomediastinum during their inpatient admission with COVID-19 and patients who developed their complication while intubated and ventilated, either with or without concurrent extracorporeal membrane oxygenation. Survival at 28 days was not significantly different following pneumothorax (63.1±6.5%) or isolated pneumomediastinum (53.0±18.7%; p=0.854). The incidence of pneumothorax was higher in males. 28-day survival was not different between the sexes (males 62.5±7.7%versus females 68.4±10.7%; p=0.619). Patients aged ≥70 years had a significantly lower 28-day survival than younger individuals (≥70 years 41.7±13.5% survival versus<70 years 70.9±6.8% survival; p=0.018 log-rank). Conclusion: These cases suggest that pneumothorax is a complication of COVID-19. Pneumothorax does not seem to be an independent marker of poor prognosis and we encourage continuation of active treatment where clinically possible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.02697-2020

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Metadata

Authors
Martinelli, A. W., Ingle, T., Newman, J., Nadeem, I., Jackson, K., Lane, N. D., Melhorn, J., Davies, H. E., Rostron, A. J., Adeni, A., Conroy, K., Woznitza, N., Matson, M., Brill, S. E., Murray, J., Shah, A., Naran, R., Hare, S. S., Collas, O., Bigham, S., Spiro, M., Huang, M. M., Iqbal, B., Trenfield, S., Ledot, S., Desai, S., Standing, L., Babar, J., Mahroof, R., Smith, I., Lee, K., Tchrakian, N., Uys, S., Ricketts, W., Patel, A. R. C., Aujayeb, A., Kokosi, M., Wilkinson, A. J. K., & Marciniak, S. J.
Venue
European Respiratory Journal
Published
2020-09-09
Volume
56
Issue
5
Pages
2002697
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W3084049187
Cited by
342
References
17
FWCI
37.06
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.